Physician profile
Wayne K Ogata
NPI 1538100953
$384.73
in general payments reported to CMS, 2019-2025
7 companies · $45.26 in 2025
The $45.26 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $56.74 · 2021: $59.62 · 2022: $21.46 · 2023: $63.56 · 2024: $138 · 2025: $45.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $202.73 | 2020-2025 | Total30, Dailies Total1 |
| Oyster Point Pharma, INC. | $63.56 | 2023 | Tyrvaya |
| Lombart Brothers, INC. | $51.68 | 2021-2024 | Opd-III |
| Iridex Corporation | $20.03 | 2020 | |
| Evolution Surgical, INC | $18.16 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $17.32 | 2025 | Xdemvy |
| Visioneering Technologies, INC. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Ogata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.